de Maat MP - Search Results

1

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.

Brouwers GJ, Leebeek FW, Tanck MW, Wouter Jukema J, Kluft C, de Maat MP. Brouwers GJ, et al. Among authors: de maat mp. Thromb Haemost. 2003 Jul;90(1):92-100. Thromb Haemost. 2003. PMID: 12876631

2

A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.

Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH. Leebeek FW, et al. Among authors: de maat mp. Gastroenterology. 1991 Nov;101(5):1382-90. doi: 10.1016/0016-5085(91)90092-y. Gastroenterology. 1991. PMID: 1718809

3

Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?

van Bergen PF, Knot EA, Jonker JJ, de Boer AC, de Maat MP. van Bergen PF, et al. Among authors: de maat mp, de boer ac. Thromb Haemost. 1989 Dec 29;62(4):1043-5. Thromb Haemost. 1989. PMID: 2694421

4

Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis.

Leebeek FW, Kluft C, Knot EA, De Maat MP. Leebeek FW, et al. Among authors: de maat mp. J Lab Clin Med. 1989 Apr;113(4):493-7. J Lab Clin Med. 1989. PMID: 2703760

5

Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).

de Maat MP, Kluft C, de Boer K, Knot EA, Jie AF. de Maat MP, et al. Among authors: de boer k. Thromb Res. 1988 Dec 1;52(5):425-30. doi: 10.1016/0049-3848(88)90026-6. Thromb Res. 1988. PMID: 3146821

6

de Maat MP, de Knijff P, Green FR, Thomas AE, Jespersen J, Kluft C. de Maat MP, et al. Among authors: de knijff p. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):856-60. doi: 10.1161/01.atv.15.7.856. Arterioscler Thromb Vasc Biol. 1995. PMID: 7600117

7

Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

de Maat MP, de Bart AC, Hennis BC, Meijer P, Havelaar AC, Mulder PG, Kluft C. de Maat MP, et al. Among authors: de bart ac. Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1156-62. doi: 10.1161/01.atv.16.9.1156. Arterioscler Thromb Vasc Biol. 1996. PMID: 8792769

8

Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.

de Maat MP, Arnold AE, van Buuren S, Wilson JH, Kluft C. de Maat MP, et al. Thromb Haemost. 1996 Aug;76(2):166-70. Thromb Haemost. 1996. PMID: 8865524 Clinical Trial.

9

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy.

Myrup B, de Maat M, Rossing P, Gram J, Kluft C, Jespersen J. Myrup B, et al. Thromb Res. 1996 Feb 15;81(4):485-90. doi: 10.1016/0049-3848(96)00021-7. Thromb Res. 1996. PMID: 8907298 Clinical Trial.

10

Modulation of plasma fibrinogen levels by ciprofibrate and gemfibrozil in primary hyperlipidaemia.

de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C. de Maat MP, et al. Thromb Haemost. 1997 Jan;77(1):75-9. Thromb Haemost. 1997. PMID: 9031453 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters